Despite emerging research highlighting differences in outcomes among GLP-1 medications, healthcare professionals in India continue to prescribe these drugs using well-established clinical guidelines rather than relying solely on the latest study findings. According to leading endocrinologist Dr. Anoop Misra Mithal, GLP-1 receptor agonists are currently prescribed based on standard eligibility criteria that focus on a [...] The post Semaglutide Remains Preferred GLP-1 Therapy in India as Doctors